QR Code

Current clinical application of serum biomarkers to detect and monitor ovarian cancer – update

In recent decades many potential serum biomarkers have been assessed in the diagnosis of ovarian cancer. Except cancer antigen 125 (CA125) and human epididymis protein 4 (HE4), none of them have been applied to everyday clinical practice. Based on extensive scientific evidence, CA125 combined with H...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Łukasz Janas, Ewa Kalinka, Marek Nowak
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Termedia Publishing House 2022-01-01
Rangatū:Menopause Review
Ngā marau:
Urunga tuihono:https://www.termedia.pl/Current-clinical-application-of-serum-biomarkers-to-detect-and-monitor-ovarian-cancer-update,4,46144,1,1.html
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!